Core Viewpoint - The announcement details the unlocking of 3,172,332 restricted shares of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., representing 0.25% of the company's total share capital as of the announcement date [1][19][25]. Summary by Relevant Sections Restricted Stock Incentive Plan - The company has completed the necessary approval procedures for the 2021 restricted stock incentive plan, including independent opinions from directors and verification from the supervisory board [1][2][4]. - The plan was approved by the State-owned Assets Supervision and Administration Commission, allowing the implementation of the restricted stock incentive plan [2]. Unlocking Conditions - The second unlocking period for the initially granted restricted shares is set to occur after 36 months from the registration date, allowing for the release of one-third of the granted shares [11][19]. - The conditions for unlocking include no negative audit opinions on financial reports and compliance with performance metrics, such as a compound annual growth rate of at least 10% for net profit attributable to shareholders [11][12][19]. Share Capital Changes - Following the completion of the restricted stock grant registration, the total number of shares increased from 978,900,000 to 987,140,000 shares [4][19]. - The total number of shares after the unlocking will be adjusted accordingly, with the total share capital reaching 1,284,298,685 shares post-unlocking [24][25]. Performance Assessment - The performance assessment for unlocking the shares requires that the individual performance of the incentive recipients meets certain criteria, with a minimum performance rating of C [17][19]. - The company has outlined specific performance metrics that must be achieved for the unlocking of shares, including total asset turnover rates and net profit growth compared to industry averages [12][14][19]. Legal and Compliance - The supervisory board and legal advisors have confirmed that the unlocking of shares complies with relevant laws and regulations, ensuring that the rights of shareholders are protected [25][26]. - The company is required to fulfill its disclosure obligations regarding the unlocking of shares as per regulatory requirements [26].
华润三九: 关于2021年限制性股票激励计划首次授予部分第二个解锁期解除限售股份上市流通的公告